The Traderszone Network

Published in TZ Latest News 17 May, 2015 by The TZ Newswire Staff

4 Reasons Why MannKind Could Succeed Where Pfizer Failed

9 years ago Pfizer tried to launch an inhaled insulin called Exubera to the market and it failed. Here are 4 reasons why Afrezza could succeed where Pfizer came up short.